Another obvious move: MRNA (Moderna), owner of the second approved Covid vaccine is my December investment February 2, 2021
Posted by deminvest in growth stock, Nasdaq stock.Tags: Covid, Moderna, mrna
add a comment
They have a new vaccine and they working on more RNA vaccines. Why not buy a company that could help save the World?
Awfully expensive: Price/Sales 244.58, but that is to be expected for Biotech companies, that basically do research work until they go broke or find some new effective Pharmaceutical product.
Risky bet.
We’ll see what happens.
My easy, obvious November investment: Pfizer PFE and Biontech BNTX November 27, 2020
Posted by deminvest in growth stock, healtcare, Nasdaq stock.Tags: Biontech, BNTX, Covid, PFE, Pfizer, Vaccine
add a comment
Pfizer and Biontech announced completing Phase 3 for their Covid vaccine on Nov 10, but their stocks showed little progress in November:
2% less than S&P 500 for PFE and 15 % more for BNTX, which, as a small company, should benefit more than that just because of lifting their brand in the spotline.
Democratic Investments by the people for the people 